How Long Does Allopurinol Take?
Allopurinol starts lowering serum urate within a few days, and each dose usually reaches its new steady level within about two weeks. Clearing the crystal deposits already sitting in your joints takes far longer — many months, often more than a year. Those are two different clocks, and confusing them is why so many people decide allopurinol is not working when it is working perfectly well.
The short version: judge the drug on your blood result, not on how you feel in month two.
Clock one: the blood level
Allopurinol inhibits xanthine oxidase, the enzyme that converts hypoxanthine and xanthine into uric acid. Block the enzyme and production falls almost immediately; the level in your blood follows within days as your kidneys and gut clear what is already circulating.
In practice, serum urate begins dropping in the first week and settles at a new plateau roughly one to two weeks after any dose change. That is why repeat blood tests are typically arranged a few weeks after starting or increasing — earlier than that, you are measuring a level still on its way down.
This clock is fast, measurable and the only reliable feedback you have in the early months. The target is serum urate below 6 mg/dL (360 µmol/L), or below 5 mg/dL (300 µmol/L) if you have tophi. The uric acid target is what treatment is steered by.
One thing that catches people out: the starting dose is deliberately low, and is rarely the dose that gets anyone to target. Allopurinol is meant to be titrated upwards in steps, each followed by a blood test, until the number is where it needs to be. If your dose has never changed and nobody has retested you, the drug is not being given a chance. Our practical guide to allopurinol describes how that process runs.
Clock two: the crystals already in the joint
Years of high urate leave deposits on cartilage surfaces, in synovium and sometimes as visible tophi. They dissolve only when the surrounding fluid is undersaturated — which is exactly why targets sit below the saturation point rather than at the top of the “normal” range.
Dissolution is slow, because it happens from the surface inwards and depends on how much has accumulated. Small deposits may clear in months. Established tophi commonly take a year or more, and are one reason a lower target is used when they are present. Imaging studies tracking urate deposits over time show steady reduction on treatment, not a sudden disappearance.
During that period, you still have crystals in your joints. Crystals in joints mean flares are still possible. This is the single most important thing to understand about the first year.
Why flares can get worse before they get better
Starting urate-lowering therapy commonly triggers flares in the first months. As the blood level falls, deposits begin shedding crystals from their surfaces into the joint space, and the immune system reacts to them exactly as it always has.
It is expected, it is well documented, and it is why prophylaxis — usually low-dose colchicine or an anti-inflammatory — is co-prescribed for the first months of treatment. If you were not offered flare cover, that is worth raising, because it makes the early phase considerably more tolerable. We cover the mechanism in why allopurinol causes flares at first.
What these flares are not is evidence of failure. They are, if anything, evidence that deposits are dissolving. Stopping at that point resets everything: the blood level climbs back within weeks and the deposits stop shrinking. If the flares are making the treatment hard to stick with, the conversation to have with your prescriber is about better flare cover — not about abandoning the drug.
A realistic timeline
| When | What the blood level is doing | What you are likely to notice |
|---|---|---|
| Days 1–7 | Falling | Nothing. Possibly a flare as deposits start to shed |
| Weeks 2–4 | Plateaued at the new level for that dose | First follow-up blood test usually falls here |
| Months 1–6 | Stepping down with each dose increase until at target | Flares may continue; prophylaxis is doing real work |
| Months 6–12 | Stable below target | Flares becoming less frequent and less severe |
| Year 1–2+ | Stable below target | Tophi shrinking; many people reach zero attacks |
The pattern to expect is not a straight line. It is a bumpy first six to twelve months followed by a marked improvement, provided the level stays where it should be.
Worth writing down: keep your urate results with their dates somewhere you can find them — a note on your phone is plenty. It is the difference between “I’ve been on allopurinol for years” and “I’ve been on the same starting dose for three years and my last level was 7.4 mg/dL (440 µmol/L)”. Only one of those sentences gets a problem solved.
What makes the clock run slower
- A dose that was never titrated to target. The most common reason of all — the blood level never gets low enough for deposits to dissolve at any useful rate.
- Missed doses. Allopurinol’s effect is dose-dependent and continuous; intermittent taking produces an intermittent result.
- Something else raising urate. A thiazide or loop diuretic, low-dose aspirin, ciclosporin or tacrolimus can all pull in the opposite direction.
- A very large crystal burden. Decades of untreated gout leaves more to dissolve, and it takes proportionally longer.
- Reduced kidney function, which affects how the drug is dosed and how quickly the target is reached.
None of these are reasons to stop, and none of them should be acted on alone. They are reasons to ask for a urate test and a review of the dose.
When to ask questions rather than wait
Some things should not be filed under “give it time”. A rash appearing in the early weeks of allopurinol needs prompt medical attention rather than watchful waiting, because a small number of serious hypersensitivity reactions begin that way — allopurinol side effects covers what to look for. Fever, mouth ulcers or feeling unwell alongside a rash warrant urgent assessment.
Separately, a single hot, swollen, intensely painful joint with fever can be septic arthritis rather than a gout flare. That is an emergency needing same-day assessment, not something to attribute to the new medication.
What “working” actually looks like
Gout is not cured, but it is controlled — frequently to no attacks at all — when urate stays below target long enough for the crystal reservoir to clear. Success at three months looks like a blood result under target and possibly a flare or two. Success at eighteen months looks like nothing happening, which is easy to mistake for not needing the treatment any more. It is not the same thing; the level climbs back within weeks of stopping, and any decision about stopping belongs with your prescriber.
Frequently Asked Questions
How soon should I have a blood test after starting allopurinol?
Usually a few weeks, once the level has settled at its new plateau, and again after each dose change. If nobody has arranged one, ask — treatment cannot be steered without it.
Should I stop allopurinol during a gout attack?
No. Standard practice is to continue it through a flare and treat the flare separately, because stopping and restarting can itself provoke attacks. Any change to your dose is your prescriber’s decision.
Why am I still getting attacks after a year on allopurinol?
Either the level is not actually at target — the usual answer, and easily checked — or the crystal burden was large enough to still be clearing. The blood result tells you which.
Does febuxostat work faster than allopurinol?
The blood-level clock is broadly similar; the crystal-dissolution clock depends on the level achieved rather than the drug used. Allopurinol vs febuxostat compares them properly.
How long does allopurinol take to work for gout?
It starts lowering the blood urate level within days, but reaching the target level usually takes weeks to months while the dose is adjusted. Flares can continue through the first six to twelve months, and many people see fewer and milder attacks after the first year. Your blood tests, not how you feel, show whether it is working.
Can allopurinol make a gout attack worse?
It can trigger flares in the first months, as deposits begin to shed crystals into the joint. That is expected, and flare cover such as low-dose colchicine is usually prescribed for this phase. It is not a reason to stop on your own; talk to your prescriber about better flare cover. A rash, fever or mouth ulcers is different and needs prompt medical attention.
Allopurinol or febuxostat: which is safer?
Neither is simply safer. Febuxostat carries a warning about cardiovascular risk in people with heart disease, while allopurinol carries a small risk of serious skin reactions that is higher in some ancestries. Your kidney function, heart history and other medicines all matter, so this is a decision for your prescriber, not a general ranking.
What to read next
- Allopurinol for Gout: A Practical Guide
- Why Allopurinol Causes Flares at First
- The Uric Acid Target That Actually Matters
- Allopurinol Side Effects: An Honest Look
